PRPO logo

Precipio, Inc. Stock Price

NasdaqCM:PRPO Community·US$54.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

PRPO Share Price Performance

US$30.45
16.26 (114.59%)
US$30.45
16.26 (114.59%)
Price US$30.45

PRPO Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and overvalued.

1 Risk
1 Reward

Precipio, Inc. Key Details

US$27.2m

Revenue

US$15.2m

Cost of Revenue

US$12.0m

Gross Profit

US$13.2m

Other Expenses

-US$1.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.68
44.11%
-4.47%
2.2%
View Full Analysis

About PRPO

Founded
n/a
Employees
66
CEO
Ilan Danieli
WebsiteView website
www.precipiodx.com

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Recent PRPO News & Updates

Recent updates

No updates